multiple sclerosis acetyl l carnitine Acetyl-L-Carnitine Acetyl-L-Carnitine in Dementia and Other
Description
Mo Farah explains why he changed story told to US anti-doping agency on taking L-carnitine Farah initially insisted he had never taken the substance, then returned to say that he had Bookmark CommentsGo to comments Sir Mo Farah has explained how he came to change his account when questioned in 2015 about taking supplement L-carnitine before the 2014 London Marathon
Limited time only
Long-term effect of acetyl-L-carnitine for antiretroviral toxic neuropathy
Total Parenteral Nutrition and Carnitine were considered adequate as descriptors (MeSH)
